Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Times Interest Earned (2016 - 2025)

Northwest Biotherapeutics (NWBO) has 16 years of Times Interest Earned data on record, last reported at -$5.46 in Q3 2025.

  • For Q3 2025, Times Interest Earned rose 23.22% year-over-year to -$5.46; the TTM value through Sep 2025 reached -$7.6, up 21.49%, while the annual FY2024 figure was -$8.56, 19.15% up from the prior year.
  • Times Interest Earned reached -$5.46 in Q3 2025 per NWBO's latest filing, up from -$8.09 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$5.46 in Q3 2025 and bottomed at -$15.37 in Q2 2021.
  • Average Times Interest Earned over 5 years is -$10.5, with a median of -$10.39 recorded in 2024.
  • Peak YoY movement for Times Interest Earned: soared 52.26% in 2022, then crashed 95.52% in 2023.
  • A 5-year view of Times Interest Earned shows it stood at -$15.37 in 2021, then grew by 3.16% to -$14.89 in 2022, then grew by 18.11% to -$12.19 in 2023, then skyrocketed by 39.01% to -$7.44 in 2024, then increased by 26.52% to -$5.46 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$5.46 in Q3 2025, -$8.09 in Q2 2025, and -$10.81 in Q1 2025.